Clinical Trial Detail

NCT ID NCT01466972
Title Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Hope Rugo, MD
Indications

breast carcinoma

Therapies

Pazopanib

Age Groups: adult senior

Additional content available in CKB BOOST